S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
3 Free Stock Picks per Day (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed

Privia Health Group (PRVA) Stock Forecast, Price & News

$24.48
+0.04 (+0.16%)
(As of 05/26/2023 ET)
Compare
Today's Range
$24.23
$24.57
50-Day Range
$24.44
$29.93
52-Week Range
$20.64
$44.64
Volume
544,724 shs
Average Volume
2.33 million shs
Market Capitalization
$2.83 billion
P/E Ratio
222.55
Dividend Yield
N/A
Price Target
$39.19

Privia Health Group MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
60.1% Upside
$39.19 Price Target
Short Interest
Bearish
5.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.68mentions of Privia Health Group in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$551.84 M Sold Last Quarter
Proj. Earnings Growth
39.13%
From $0.23 to $0.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.51 out of 5 stars

Medical Sector

152nd out of 1,012 stocks

Health Services Industry

2nd out of 12 stocks


PRVA stock logo

About Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

Privia Health Group (NASDAQ:PRVA) Stock Price Down 7.5%
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
RBC Capital Remains a Buy on Privia Health Group (PRVA)
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Company Calendar

Last Earnings
2/28/2023
Today
5/28/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
810
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$39.19
High Stock Price Forecast
$51.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+60.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
0.12%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.81 per share

Miscellaneous

Free Float
49,041,000
Market Cap
$2.83 billion
Optionable
Not Optionable
Beta
0.77

Key Executives

  • Mr. Matthew Shawn MorrisMr. Matthew Shawn Morris (Age 58)
    CEO & Director
    Comp: $1.46M
  • Mr. Parth  MehrotraMr. Parth Mehrotra (Age 43)
    Pres & COO
    Comp: $1.21M
  • Mr. Thomas  BartrumMr. Thomas Bartrum (Age 55)
    Exec. VP & Gen. Counsel
    Comp: $536.6k
  • Mr. David  Mountcastle CPAMr. David Mountcastle CPA (Age 51)
    MBA, Exec. VP, CFO & Principal Accounting Officer
  • Mr. Chris Voigt
    Exec. VP & Chief Technology Officer
  • Mr. Robert P. Borchert
    Sr. VP of Investor Relations & Corp. Communications
  • Ms. Dana Fields CPA
    Sr. VP of Internal Audit & Chief Compliance Officer
  • Ms. Jenny Harding
    Sr. VP of People Operations
  • Mr. Jay Stevens
    Sr. VP & Chief Growth Officer
  • Dr. Jim Sams M.D.
    CEO of Privia Medical Group - Georgia & Physician Exec. of Privia Medical Group - Tennessee













PRVA Stock - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price forecast for 2023?

13 Wall Street research analysts have issued 1-year price objectives for Privia Health Group's shares. Their PRVA share price forecasts range from $28.00 to $51.00. On average, they predict the company's share price to reach $39.19 in the next year. This suggests a possible upside of 60.1% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 on January 1st, 2023. Since then, PRVA stock has increased by 7.8% and is now trading at $24.48.
View the best growth stocks for 2023 here
.

Are investors shorting Privia Health Group?

Privia Health Group saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,740,000 shares, an increase of 189.9% from the April 30th total of 1,980,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is currently 4.9 days. Currently, 5.4% of the company's shares are short sold.
View Privia Health Group's Short Interest
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) issued its earnings results on Tuesday, February, 28th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.17. The business had revenue of $364.42 million for the quarter, compared to the consensus estimate of $337.16 million. Privia Health Group had a trailing twelve-month return on equity of 3.20% and a net margin of 1.14%.

What guidance has Privia Health Group issued on next quarter's earnings?

Privia Health Group issued an update on its FY 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.55 billion-$1.65 billion, compared to the consensus revenue estimate of $2.79 billion.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is Privia Health Group's stock symbol?

Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (3.99%), Bank of New York Mellon Corp (3.09%), Principal Financial Group Inc. (1.99%), Riverbridge Partners LLC (1.96%), FMR LLC (1.47%) and Franklin Resources Inc. (1.09%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends
.

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Privia Health Group's stock price today?

One share of PRVA stock can currently be purchased for approximately $24.48.

How much money does Privia Health Group make?

Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.83 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does Privia Health Group have?

The company employs 810 workers across the globe.

How can I contact Privia Health Group?

The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.

This page (NASDAQ:PRVA) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -